Software quality for safety-critical medical devices has been at the center of discussion for industry experts and especially the FDA. In 2010, 39 of medical device recalls (500 total recalls over the past 7 years) were reported to be related to software defects and malfunctions. According to an FDA survey, this equates to approximately 8% […]
Filed under: IT / Internet / E-mail on March 30th, 2011 | No Comments »
BIOTRONIK SE & Co. KG, a leading manufacturer of cardiac devices, announced today that the last chronic heart failure (HF) patient was enrolled in IN-TIME at the Schwabing Clinic in Munich, Germany, with principle investigator Professor Stefan Sack, MD…
More: continued here
Filed under: Cardiovascular on March 30th, 2011 | No Comments »
ExonHit Therapeutics (Paris:ALEHT) today announced successful completion of the first phase of the validation study of EHT Dx14, a new transcriptomic signature allowing to differentiate, at molecular level, benign breast tumors from malignant ones…
More: continued here
Filed under: Breast Cancer on March 30th, 2011 | No Comments »
Rite Aid immunizing pharmacists at more than 2,100 stores can now vaccinate patients over the age of 50 against shingles. On March 24, the Food and Drug Administration (FDA) expanded the age eligibility for the shingles vaccine, Zostavax, which previously was only approved for patients over the age of 60…
More: continued here
Filed under: Immune System / Vaccines on March 30th, 2011 | No Comments »
Female athletes who sustain a concussion report different symptoms than their male counterparts, according to research performed at the University of Virginia’s Curry School of Education…
More: continued here
Filed under: Neurology / Neuroscience on March 30th, 2011 | No Comments »
Some people with diabetes type 1 spend fifty or more years with the condition and have no complications at all, while others develop proliferative diabetic retinopathy, nephropathy (kidney damage), neuropathy (nerve damage) or cardiovascular disease…
More: continued here
Filed under: Diabetes on March 30th, 2011 | No Comments »
Parents and teachers have been wondering for decades whether food dyes might undermine children’s concentration spans and make them hyperactive. Now the Food and Drug Administration is investigating whether such a link actually exists. An FDA-advisory committee starts a two-day meeting today to determine whether food dyes are associated with hyperactivity, according to available data…
More: […]
Filed under: ADHD on March 30th, 2011 | No Comments »
Concert Pharmaceuticals, Inc. today announced it has made significant progress advancing CTP-499, its novel anti-inflammatory, anti-oxidant, and anti-fibrotic agent for diabetic nephropathy and other forms of chronic kidney disease, into clinical development…
More: continued here
Filed under: Clinical Trials on March 30th, 2011 | No Comments »
The results from a new CIGNA study support that there is a potential association between treated periodontal (gum) disease and reduced medical costs for patients with diabetes. The findings of the three-year claims study were presented during a recent meeting of the International Association for Dental Research (IADR) in San Diego. The study was […]
Filed under: Dentistry on March 30th, 2011 | No Comments »
In the longest study of its kind, bariatric surgery has been shown to reduce the risk of heart attack and stroke in patients with diabetes. These results and other groundbreaking research were presented at the 2nd World Congress on Interventional Therapies for Type 2 Diabetes, hosted by NewYork-Presbyterian Hospital and Weill Cornell Medical College…
More: […]
Filed under: Cardiovascular on March 30th, 2011 | No Comments »